| Alexion Pharma GmbH - Ultomiris 300 mg/3 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 67278 | | 02 | | Ultomiris 300 mg/3 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L04AJ02 | | Ravulizumab | | 16.09.2021 | | |
|
| Composition |
| ravulizumabum 300 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, argininum, saccharum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium 4.6 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Ravulizumabum | 300mg / 3ml |
| | BAG: Active Agent | Dose |
|---|
| Ravulizumabum | 300 mg |
| | | | Inactive agents |
|---|
| Arginine | | Disodium Phosphate Heptahydrate | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | | 4035.23 | 4181.20 | A | SL | No |
|
